A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen-Reference-Cited by-同舟云学术

A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen

Published:2012-02 Issue:2 Volume:18 Page:324-329
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Satwani Prakash,Bhatia Monica,Garvin James H.,George Diane,Dela Cruz Filemon,Le Gall John,Jin Zhezhen,Schwartz Joseph,Duffy Deirdre,van de Ven Carmella,Foley Sandra,Hawks Ria,Morris Erin,Baxter-Lowe Lee Ann,Cairo Mitchell S.

Funder

Pediatric Cancer Research Foundation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference43 articles.

1. Epidemiology of childhood acute myelogenous leukemia;Bhatia;J Pediatr Hematol Oncol,1995

2. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93;Creutzig;J Clin Oncol,2001

3. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. MRC Childhood Leukaemia Working Party;Stevens;Br J Haematol,1998

4. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission;Woods;Blood,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches;Biochemical Pharmacology;2023-09

2. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas;Cancers;2022-10-14

3. Worked to the bone: antibody-based conditioning as the future of transplant biology;Journal of Hematology & Oncology;2022-05-19

4. Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin;Cancers;2021-09-11

5. The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia;Journal of Clinical Medicine;2021-08-25